Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Health Fund

+ Add to Watchlist

AXAHLZA:LN

200.50 GBp 1.90 0.96%

As of 00:59:30 ET on 01/30/2015.

Snapshot for AXA Framlington Health Fund (AXAHLZA)

Year To Date: +6.48% 3-Month: +12.39% 3-Year: - 52-Week Range: 141.87 - 202.60
1-Month: +6.48% 1-Year: +34.68% 5-Year: - Beta vs FTWBWRLD: 0.92

Mutual Fund Chart for AXAHLZA

No chart data available.
  • AXAHLZA:LN 200.50
  • 1M
  • 1Y
Interactive AXAHLZA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for AXAHLZA

AXA Framlington Health Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to achieve capital growth. It invests in producers of pharmaceuticals, bio-technology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies along ethical guidelines.

Inception Date: 04-16-2012 Telephone: 44-207-374-4100
Managers: GEMMA GAME
Web Site: www.axa-framlington.com

Fundamentals for AXAHLZA

NAV (on 2015-01-30) 200.50
Assets (M) (on 2014-11-27) 462.05
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 5,000.00

Dividends for AXAHLZA

Dividend Type Accumulation
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-11-03) 0.24
Dividend Yield (ttm) 0.13

Fees & Expenses for AXAHLZA

Front Load 0.00
Back Load -
Current Mgmt Fee 0.75
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for AXAHLZA

Filing Date: 11/28/2014
Name Position Value % of Total
Roche Holding AG 133,283 25,553,000 5.500%
Novartis AG 367,532 22,765,400 4.900%
Gilead Sciences Inc 332,823 21,371,600 4.600%
UnitedHealth Group Inc 221,610 13,938,000 3.000%
Amgen Inc 131,724 13,938,000 3.000%
AbbVie Inc 283,205 12,544,200 2.700%
Celgene Corp 172,379 12,544,200 2.700%
Express Scripts Holding Co 209,504 11,150,400 2.400%
McKesson Corp 75,767 10,221,200 2.200%
Actavis plc 56,327 9,756,600 2.100%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil